Xuerong Biotech (300511.SZ) released its report for the first quarter of 2024. The company achieved operating income during the reporting period...
According to Zhitong Finance App, Xuerong Biotech (300511.SZ) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 604 million yuan, a year-on-year decrease of 28.30%; net profit attributable to shareholders of listed companies was 5.2403 million yuan, a year-on-year decrease of 97.65%; shareholders attributable to listed companies deducted non-recurring net profit and loss of 3.54 million yuan per share; basic earnings per share.